This document is available in three formats: this web page (for browsing content), PDF (comparable to original document formatting), and WordPerfect.  To view the PDF you will need Acrobat Reader, which may be downloaded from the Adobe site. For an official signed copy, please contact the Antitrust Documents Group

IN THE UNITED STATES DISTRICT COURT
FOR THE NORTHERN DISTRICT OF TEXAS



UNITED STATES OF AMERICA,  
                  Plaintiff,

                  v.

ANTONIO FELIX,  
               Defendant.


|
|
|
|
|
|
|
|
|
|         

Criminal No.: 399-CR-067-P

Filed: 03/02/1999

Violation: 15 U.S.C. 1

Judge Solis



INFORMATION

The United States of America, acting through its attorneys, charges:

I
DESCRIPTION OF THE OFFENSE

  1. Antonio Felix is hereby made a defendant on the charge stated below.

  2. Beginning at least as early as January 1988 and continuing until at least September 29, 1998, the exact dates being unknown to the United States, the defendant and co-conspirators entered into and participated in a combination and conspiracy to suppress and eliminate competition by fixing the price of, allocating customers for, and the volume of, choline chloride sold in the United States and elsewhere. The defendant joined the conspiracy at least as early as August 1995. The combination and conspiracy engaged in by the defendant and co-conspirators was in unreasonable restraint of interstate and foreign trade and commerce in violation of Section 1 of the Sherman Act (15 U.S.C. § 1).

  3. The charged combination and conspiracy consisted of a continuing agreement, understanding, and concert of action among the defendant and co-conspirators, the substantial terms of which were:

    1. to agree to fix and maintain prices and to coordinate price increases for the sale of choline chloride in the United States and elsewhere;

    2. to agree to allocate among the corporate conspirators the volume of sales of choline chloride in the United States and elsewhere;

    3. to agree to allocate among the corporate conspirators customers of choline chloride in the United States and elsewhere;

    4. to allocate among the corporate conspirators all or part of certain contracts to supply choline chloride to various customers located throughout the United States;

    5. to refrain from submitting bids, or to submit collusive, non-competitive, and rigged bids to supply choline chloride to various customers located in the United States; and

    6. to supply choline chloride to various customers located throughout the United States at non-competitive prices and receive compensation therefore.

  4. For the purpose of forming and carrying out the charged combination and conspiracy, the defendant and co-conspirators did those things that they combined and conspired to do, including, among other things:

    1. participating in meetings and conversations in the United States and elsewhere to discuss the prices and volume of choline chloride sold in the United States and elsewhere;

    2. agreeing, during those meetings and conversations, to charge prices at specified levels and otherwise to increase and maintain prices of choline chloride sold in the United States and elsewhere;

    3. agreeing, during those meetings and conversations, to allocate among the corporate conspirators the approximate volume of choline chloride to be sold by each corporate conspirator in the United States and elsewhere;

    4. agreeing, during those meetings and conversations, to allocate among the corporate conspirators customers of choline chloride in the United States and elsewhere;

    5. agreeing, during those meetings and conversations, to divide markets worldwide for choline chloride among the corporate conspirators;

    6. agreeing, during those meetings and conversations, to restrict choline chloride producing capacity among the corporate conspirators;

    7. exchanging sales and customer information for the purpose of monitoring and enforcing adherence to the above-described agreement;

    8. issuing price announcements and price quotations in accordance with the agreements reached;

    9. discussing among co-conspirators the submission of prospective bids to supply choline chloride to customers located throughout the United States;

    10. designating which corporate conspirator would be the designated low bidder for contracts to supply choline chloride to customers located throughout the United States;

    11. discussing and agreeing upon prices to be contained within the bids for contracts to supply choline chloride to customers in the United States;

    12. refraining from bidding or submitting intentionally high, complementary bids for the contracts to supply choline chloride to customers in the United States; and

    13. supplying choline chloride to various customers in the United States at non-competitive prices and receiving compensation therefore.

    II
    BACKGROUND

  5. Choline chloride is a vitamin of the B-complex group. Choline chloride, or vitamin B4, is sold by manufacturers and resellers to customers in the animal nutrition industry. Choline chloride is an ingredient necessary for the proper growth and development of animals.

    III
    DEFENDANT AND CO-CONSPIRATORS

  6. Beginning at least as early as August 1995, Antonio Felix was employed as the Vice President of the Basic Products and International Division for DuCoa, L.P., a United States joint venture between DuPont de Nemours and Company (DuPont), a United States corporation with its principal place of business in Wilmington, Delaware, and ConAgra, Inc., a United States corporation with its principal place of business in Omaha, Nebraska. DuCoa, L.P.'s principal place of business is in Highland, Illinois. DuCoa, L.P. manufactures choline chloride in Highland, Illinois and is engaged in the sale of choline chloride throughout the United States and elsewhere.

  7. Various corporations and individuals not made defendants herein participated as co-conspirators in the offense charged herein and performed acts and made statements in furtherance thereof.

  8. Wherever in this Information reference is made to any act, deed, or transaction of a corporation, the allegation means that the corporation engaged in the act, deed, or transaction by or through its officers, directors, agents, employees, or representatives while they were actively engaged in the management, direction, control, or transaction of its business or affairs.

    IV
    TRADE AND COMMERCE

  9. During the period covered by this Information, the defendant and co-conspirators sold and distributed a substantial quantity of choline chloride in a continuous and uninterrupted flow of interstate and foreign trade and commerce to customers located in states or countries other than the states or countries in which the choline chloride was produced.

  10. During the period covered by this Information, the activities of the defendant and co-conspirators that are the subject of this Information were within the flow of, and substantially affected, interstate and foreign trade and commerce.

    V
    JURISDICTION AND VENUE

  11. The combination and conspiracy charged in this Information was carried out, in part, within the Northern District of Texas within the five years preceding the filing of this Information.

ALL IN VIOLATION OF TITLE 15, UNITED STATES CODE, SECTION 1.

Dated:

_______________/s/________________
JOEL I. KLEIN
Assistant Attorney General

_______________/s/________________
GARY R. SPRATLING
Deputy Assistant Attorney General

_______________/s/________________
JAMES M. GRIFFIN
Director of Criminal Enforcement
Antitrust Division
U.S. Department of Justice

                    _______________/s/________________
ALAN A. PASON
Chief, Dallas Office

_______________/s/________________
GREGORY S. GLOFF
MITCHELL R. CHITWOOD
Attorneys, Antitrust Division

U.S. Department of Justice
Dallas Field Office
Thanksgiving Tower
1601 Elm Street, Suite 4950
Dallas, Texas 75201-4717
Tel.: (214) 880-9401